Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All
skeeze / Pixabay

Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All

According to a story from The Intercept, Ady Barkan's life is slowly slipping away as his amyotrophic lateral sclerosis continues to progress. Despite this, Ady has developed a reputation as…

Continue Reading Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All
Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis
rawpixel / Pixabay

Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis

According to a story from Ankylosing Spondylitis News, a recent study has reaffirmed the understanding that patients with ankylosing spondylitis, a rare form of inflammatory disease that affects the joints…

Continue Reading Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis
Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US
geralt / Pixabay

Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US

According to a story from Lambert-Eaton News, a recent large scale study using data from the Veterans Affairs has determined that the prevalence of Lambert-Eaton myasthenic syndrome (LEMS) is similar…

Continue Reading Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
Baby’s Death in Spinal Muscular Atrophy Gene Therapy Trial Could be Linked to Treatment, Company Says
geralt / Pixabay

Baby’s Death in Spinal Muscular Atrophy Gene Therapy Trial Could be Linked to Treatment, Company Says

According to a story from BNN Bloomberg, Novartis AG, a drug company that is nearing the completion of the development of a potentially groundbreaking new gene therapy for spinal muscular…

Continue Reading Baby’s Death in Spinal Muscular Atrophy Gene Therapy Trial Could be Linked to Treatment, Company Says
Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims
mohamed_hassan / Pixabay

Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims

According to a story from Healio, a recent study has found that 58 percent of patients with the inflammatory disease ankylosing spondylitis will experience relapse within one year after stopping…

Continue Reading Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims
Analysis of Hepatocellular Carcinoma Trial Presented at 2019 Gastrointestinal Cancers Symposium
MariSmithPix / Pixabay

Analysis of Hepatocellular Carcinoma Trial Presented at 2019 Gastrointestinal Cancers Symposium

According to a story from finanzen.ch, the pharmaceutical company Eisai, Inc. announced that that company presented a total of four abstracts which were related to a Phase 3 clinical trial…

Continue Reading Analysis of Hepatocellular Carcinoma Trial Presented at 2019 Gastrointestinal Cancers Symposium
As UK Cystic Fibrosis Patients Push for Drug Coverage, a Girl That Died too Soon Becomes the Face of the Campaign
Walkerssk / Pixabay

As UK Cystic Fibrosis Patients Push for Drug Coverage, a Girl That Died too Soon Becomes the Face of the Campaign

According to a story from express.co.uk, Elle Morris was only 11 years old when she died from a severe lung infection. Elle was born with cystic fibrosis, a serious genetic…

Continue Reading As UK Cystic Fibrosis Patients Push for Drug Coverage, a Girl That Died too Soon Becomes the Face of the Campaign

Early Trial Data Suggests Safety and Potential Efficacy of Experimental Drug in Treating Advanced Hepatocellular Carcinoma

According to a story from BioPortfolio, the biotechnology company Tiziana Life Sciences plc recently announced encouraging results from an interim safety review of the company's Phase 2a clinical trial. This…

Continue Reading Early Trial Data Suggests Safety and Potential Efficacy of Experimental Drug in Treating Advanced Hepatocellular Carcinoma
Recent Study Indicates That SPINRAZA can Benefit Patients with Late-Onset Spinal Muscular Atrophy
Pexels / Pixabay

Recent Study Indicates That SPINRAZA can Benefit Patients with Late-Onset Spinal Muscular Atrophy

According to a story from globenewswire.com, the biotechnology company Biogen recently released data from an open label study that was testing the company's spinal muscular atrophy drug nusinersen (marketed as…

Continue Reading Recent Study Indicates That SPINRAZA can Benefit Patients with Late-Onset Spinal Muscular Atrophy

Experimental Treatment for Neuromyelitis Optica Earns Breakthrough Therapy Designation

According to a story from BioSpace, the biotechnology company Viela Bio recently announced that the US Food and Drug Administration (FDA) has awarded an experimental therapy in development by the…

Continue Reading Experimental Treatment for Neuromyelitis Optica Earns Breakthrough Therapy Designation
New Sensor Technology Can Detect Medication Response Automatically for Parkinson’s Disease Patients
shixugang / Pixabay

New Sensor Technology Can Detect Medication Response Automatically for Parkinson’s Disease Patients

According to a story from EurekAlert!, effective management of Parkinson's disease can be a serious challenge. Part of the reason that the management of the illness is so difficult is…

Continue Reading New Sensor Technology Can Detect Medication Response Automatically for Parkinson’s Disease Patients

Companies Announce Collaboration to Develop Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

According to a story from globenewswire.com, the gene therapy company Fibrocell Science, Inc. and the biopharmaceutical company Castle Creek Pharmaceuticals have recently announced a collaboration between the two companies. The…

Continue Reading Companies Announce Collaboration to Develop Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Animal Model Study Using CRISPR Could Lead to Successful Treatment of Rare Lung Diseases

According to a story from EurekAlert!, a group of researchers affiliated with Penn Medicine and Children's Hospital of Philadelphia recently conducted an experiment in which the scientists used CRISPR gene…

Continue Reading Animal Model Study Using CRISPR Could Lead to Successful Treatment of Rare Lung Diseases